Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Anticancer Research|January 30, 2003
Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activityFumiko Arakawa, Hirotomo Shibaguchi, Zhongwei Xu, et al.
International Journal of Oncology|February 13, 2009
Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomasHideki Komatani, Yasuo Sugita, Fumiko Arakawa, et al.
Anticancer Research|December 12, 2003
cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibodyHirotomo Shibaguchi, Fumiko Arakawa, Takayuki Imakiire, et al.
Pathology International|June 27, 2014
Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphomaYing Guo, Fumiko Arakawa, Hiroaki Miyoshi, et al.
Brain Tumor Pathology|January 7, 2011
CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic targetMizuhiko Terasaki, Yasuo Sugita, Fumiko Arakawa, et al.
Hematological Oncology|August 25, 2020
Cytokine-related genes play critical roles in extrafollicular growth of follicular lymphoma cellsNoriaki Yoshida, Hiroaki Miyoshi, Fumiko Arakawa, et al.
Journal of Immunological Methods|October 16, 2002
Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patientsHironori Abe, Motomu Kuroki, Takayuki Imakiire, et al.
The Journal of Dermatology|April 15, 2003
Gamma interferon gene transfection efficiently inhibits proliferation of neurofibroma cell lines in vitroJuichiro Nakayama, Toshihiro Tanaka, Fumiko Arakawa, et al.
Pathology International|September 2, 2021
The first case of methotrexate-associated lymphoproliferative disorder presenting as follicular T-cell lymphomaReiji Muto, Toshiro Kawakita, Hiroaki Miyoshi, et al.
Pageof 6